Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-18-025549)

Filing Details

Accession Number:
0001209191-18-025549
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-19 16:07:10
Reporting Period:
2018-04-17
Accepted Time:
2018-04-19 16:07:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367920 Concert Pharmaceuticals Inc. CNCE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1353528 V James Cassella C/O Concert Pharmaceuticals, Inc.
99 Hayden Avenue, Suite 500
Lexington MA 02421		 Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-04-17 10,582 $20.18 30,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on February 8, 2018.